Treace Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Summary

Treace Medical Concepts (TMCI) announced that CEO John T. Treace and CFO Mark Hair will join a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on September 14, 2021, at approximately 4:15 PM ET. This discussion will focus on the company’s innovative Lapiplasty® 3D Bunion Correction™ procedure, designed to improve surgical treatment for bunions. A live webcast and replay will be available on the company's investor relations website.

Positive

• Participation in a prestigious healthcare conference could enhance visibility and credibility.
• Focus on innovative surgical solutions for bunion correction may attract investor interest.

Negative

• None.

PONTE VEDRA, Fla., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure, today announced that John T. Treace, Chief Executive Officer, and Mark Hair, Chief Financial Officer, will participate in a virtual fireside chat at the Morgan Stanley 19^th Annual Global Healthcare Conference on Tuesday, September 14, 2021, beginning at approximately 4:15 pm ET.

A live webcast and replay of the fireside chat will be available on the Company’s investors relations website at https://investors.treace.com/.

About Treace Medical Concepts
Treace Medical Concepts, Inc. is a commercial-stage orthopaedic medical device company with the goal of advancing the standard of care for the surgical management of bunion deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system - a combination of instruments, implants, and surgical methods designed to correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and getting patients back to their active lives quickly.

Contacts:
Treace Medical Concepts
Mark L. Hair
Chief Financial Officer
mhair@treace.net
(904) 373-5940

Investors:
Gilmartin Group
Lynn Lewis or Vivian Cervantes
IR@treace.net

FAQ

When is Treace Medical Concepts participating in the Morgan Stanley conference?

Treace Medical Concepts will participate in the Morgan Stanley conference on September 14, 2021, at approximately 4:15 PM ET.

What is the Lapiplasty® 3D Bunion Correction™ procedure?

The Lapiplasty® 3D Bunion Correction™ procedure is an innovative surgical method developed by Treace Medical Concepts to correct bunion deformities.

Who are the executives speaking at the Morgan Stanley conference for TMCI?

The executives speaking are CEO John T. Treace and CFO Mark Hair.

Where can I find the webcast for the Treace Medical Concepts fireside chat?

The live webcast and replay will be available on Treace Medical Concepts' investor relations website.